Polymorphisms in the resistin gene (RETN), such as the promoter variant rs1862513, are associated with elevated serum resistin levels, obesity susceptibility, insulin resistance, and coronary artery disease severity (7). The gene discussed is RETN; the disease is obesity disorder.